Jason T Connor

Summary

Publications

  1. pmc Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study
    Jason T Connor
    aBerry Consultants, Orlando, FL, USA
    Clin Trials 10:807-27. 2013
  2. pmc Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus
    Jason T Connor
    Berry Consultants, 4301 Westbank Dr, Suite 140, Bldg B, Austin, TX 78746, USA
    J Clin Epidemiol 66:S130-7. 2013
  3. pmc Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication
    Roger J Lewis
    Department of Emergency Medicine, Harbor UCLA Medical Center, 1000 West Carson Street, Torrance, California 90509, USA
    Trials 12:134. 2011

Collaborators

  • Roger J Lewis
  • James R Murphy
  • John R Teerlink
  • Leslie T Cooper
  • William R Hiatt
  • Eric P Brass

Detail Information

Publications3

  1. pmc Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study
    Jason T Connor
    aBerry Consultants, Orlando, FL, USA
    Clin Trials 10:807-27. 2013
    ..Randomized clinical trials, particularly for comparative effectiveness research (CER), are frequently criticized for being overly restrictive or untimely for health-care decision making...
  2. pmc Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus
    Jason T Connor
    Berry Consultants, 4301 Westbank Dr, Suite 140, Bldg B, Austin, TX 78746, USA
    J Clin Epidemiol 66:S130-7. 2013
    ..We present a novel Bayesian adaptive comparative effectiveness trial comparing three treatments for status epilepticus that uses adaptive randomization with potential early stopping...
  3. pmc Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication
    Roger J Lewis
    Department of Emergency Medicine, Harbor UCLA Medical Center, 1000 West Carson Street, Torrance, California 90509, USA
    Trials 12:134. 2011
    ..We describe the design, oversight, and implementation of an adaptive, phase II, dose-finding trial evaluating K-134 for the treatment of stable, intermittent claudication...